Other OTC - Delayed Quote • USD
Ayala Pharmaceuticals, Inc. (ADXS)
At close: April 26 at 11:14 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jan 2023) | Next Qtr. (Apr 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -3.2 | -1.6 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jan 2023) | Next Qtr. (Apr 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | 250k | 250k | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 4/30/2021 | 7/31/2021 | 10/31/2021 | 10/31/2022 |
|---|---|---|---|---|
| EPS Est. | -4 | -3.2 | -3.2 | -0.73 |
| EPS Actual | -3.2 | -1.6 | -3.2 | -2.53 |
| Difference | 0.8 | 1.6 | 0 | -1.8 |
| Surprise % | 20.00% | 50.00% | 0.00% | -246.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jan 2023) | Next Qtr. (Apr 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | -2.19 | -5.97 | -0.15 |
| 30 Days Ago | 0 | -2.19 | -5.97 | -0.15 |
| 60 Days Ago | 0 | -2.19 | -5.97 | -0.15 |
| 90 Days Ago | 0 | -2.19 | -5.97 | -0.15 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jan 2023) | Next Qtr. (Apr 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ADXS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 6.50% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | -- | -- | -- | 5.30% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | Ladenburg Thalmann: Neutral to Buy | 5/30/2023 |
Related Tickers
PYPD PolyPid Ltd.
4.7525
+4.45%
LIPO Lipella Pharmaceuticals Inc.
0.7110
+0.98%
GRI GRI Bio, Inc.
0.4300
-1.35%
IMNM Immunome, Inc.
13.73
-3.72%
XCUR Exicure, Inc.
0.5001
-1.56%
CWBR CohBar, Inc.
0.8801
+10.01%
AIM AIM ImmunoTech Inc.
0.4282
+5.34%
NBSE NeuBase Therapeutics, Inc.
0.4396
-0.54%
SLRX Salarius Pharmaceuticals, Inc.
0.4951
+2.93%
TTNP Titan Pharmaceuticals, Inc.
7.09
+0.57%